Recent Finacing
Recent Raise
Selux Diagnostics develops NGP, an automated rapid AST platform delivering <24‑hour results from blood cultures and isolates, combining biochemical assays and AI for high‑throughput testing of 50 antibiotics.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at SeLux Diagnostics.
